{
    "clinical_study": {
        "@rank": "99080", 
        "arm_group": [
            {
                "arm_group_label": "brevibloc (esmolol)", 
                "arm_group_type": "Experimental", 
                "description": "Group E will receive esmolol (1 mg/kg), Group L lidocaine (1.5 mg/kg)and Group C placebo(NaCl 0.9%, 5 mL)"
            }, 
            {
                "arm_group_label": "Aritmal (Lidocaine)", 
                "arm_group_type": "Active Comparator", 
                "description": "Group E: esmolol (1 mg/kg) Group L: lidocaine (1.5 mg/kg) Group C: placebo(NaCl 0.9%, 5 mL)"
            }, 
            {
                "arm_group_label": "Placebo (NaCl 0.9%, 5 ml)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Group E: esmolol (1 mg/kg) Group L: lidocaine (1.5 mg/kg) Group C: placebo(NaCl 0.9%, 5 mL)"
            }
        ], 
        "brief_summary": {
            "textblock": "90 American society of anesthesiology (ASA) physical status I and II patients undergoing\n      general anesthesia for elective surgery will be included in the study. Patients will be\n      randomized into three groups. Group E will receive esmolol (1 mg/kg), Group IL lidocaine\n      (1.5 mg/kg)and Group C placebo(NaCl 0.9%, 5 mL), followed by a 0.05 mg/kg rocuronium. After\n      intravenous induction with propofol, adequate muscle relaxation for intubation will be\n      received by 0.5 mg/kg rocuronium."
        }, 
        "brief_title": "Effect of Esmolol on Pain Due to Rocuronium", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Injection Site Irritation", 
        "detailed_description": {
            "textblock": "Patients will be observed after injection of rocuronium 0.05mg/kg, then immediately asked if\n      they have pain in the arm. The response are assessed; discomfort, pain, and withdrawal of\n      the hand are recorded and graded using a 4-point scale (none, mild, moderate, or severe).\n      After the intubating dose of rocuronium, withdrawal reactions are scored as follows: (a) no\n      pain response, (b)pain limited to the wrist, (c) pain limited to the elbow/shoulder, or (d)\n      generalized pain response."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA physical status I and II patients\n\n          -  Undergoing general anesthesia for elective surgery\n\n        Exclusion Criteria:\n\n          -  Known allergy to esmolol or lidocaine\n\n          -  Chronic pain\n\n          -  Pregnancy\n\n          -  Withdrawal of consent by the patient"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01824758", 
            "org_study_id": "ESM 0538"
        }, 
        "intervention": [
            {
                "arm_group_label": "Aritmal (Lidocaine)", 
                "description": "Group L lidocaine (1.5 mg/kg), (rocuronium) (0.05mg/kg).", 
                "intervention_name": "Lidocaine", 
                "intervention_type": "Drug", 
                "other_name": "Aritmal, Jetmonal"
            }, 
            {
                "arm_group_label": "brevibloc (esmolol)", 
                "description": "Group E: esmolol (1 mg/kg), (rocuronium) (0.05mg/kg)", 
                "intervention_name": "Esmolol", 
                "intervention_type": "Drug", 
                "other_name": "brevibloc"
            }, 
            {
                "arm_group_label": [
                    "brevibloc (esmolol)", 
                    "Aritmal (Lidocaine)", 
                    "Placebo (NaCl 0.9%, 5 ml)"
                ], 
                "description": "0.05 mg/kg rocuronium", 
                "intervention_name": "rocuronium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo (NaCl 0.9%, 5 ml)", 
                "description": "Group C: Placebo (NaCl 0.9%, 5 ml), (rocuronium) (0.05mg/kg)", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Lidocaine", 
                "Rocuronium", 
                "Esmolol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "esmolol, injection pain, lidocaine, rocuronium", 
        "lastchanged_date": "April 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "state": "Altindag"
                }, 
                "name": "Diskapi Teaching and Research Hospital"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Effect of Esmolol on Pain Due to Rocuronium Injection Pain", 
        "other_outcome": {
            "measure": "To assess patient satisfaction", 
            "safety_issue": "Yes", 
            "time_frame": "1 Month"
        }, 
        "overall_contact": {
            "email": "fatmakavak@yahoo.com", 
            "last_name": "fatma k. akelma", 
            "phone": "905327079113"
        }, 
        "overall_contact_backup": {
            "email": "julideergil@hotmail.com", 
            "last_name": "j\u00fclide ergil", 
            "phone": "905323469216"
        }, 
        "overall_official": {
            "affiliation": "Diskapi Teaching and Research Hospital", 
            "last_name": "Fakelma 05327079113", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain will be recorded and graded using a 4-point scale (none, mild, moderate, or severe).", 
            "measure": "The injection pain due to rocuronium", 
            "safety_issue": "Yes", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01824758"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Etlik Zubeyde Hanim Womens' Health and Teaching Hospital", 
            "investigator_full_name": "Fatma Kavak Akelma", 
            "investigator_title": "Specialist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Withdrawal reactions are scored as follows: (a) no pain response, (b)pain limited to the wrist, (c) pain limited to the elbow/shoulder, or (d) generalized pain response.", 
            "measure": "Score on  pain due to injection of rocuronium", 
            "safety_issue": "Yes", 
            "time_frame": "1 month"
        }, 
        "source": "Etlik Zubeyde Hanim Womens' Health and Teaching Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Etlik Zubeyde Hanim Womens' Health and Teaching Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}